Verastem, Inc. to Present Scientific Results at the 2013 American Association for Cancer Research Annual Meeting
Verastem, Inc., (NASDAQ: VSTM) a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced the presentation of preclinical data at the American Association for Cancer Research annual meeting being held April 6 - 10, 2013, at the Walter E. Washington Convention Center in Washington, DC.